Search Browse Earnings

Embecta Corp. — SlamSEC

Embecta Corp.

Nasdaq:EMBC

Surgical & Medical Instruments & Apparatus·WILMINGTON, DE

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$1.1B

-0.8% YoY

FY 2025

Adj. EBITDA

$254.1M

22.7% margin

FY 2025

Net Income

$70.4M

6.3% margin

FY 2025

EPS (Diluted)

$1.22

FY 2025

Stock Price

$9.09

-1.6%

2026-03-10

52W Range

$8.81 – $15.55

P/E Ratio

7.5x

Market Cap

$538.3M

Cash

$267.5M

FY 2025

Total Debt

$1.6B

FY 2025

Net Debt

$1.3B

FY 2025

Enterprise Value

$1.8B

Debt / EBITDA

5.1x

FY 2025

EV / EBITDA

7.2x

Employees

—